Trajan Group Holdings Ltd (AU:TRJ)
ASX:TRJ
Want to see AU:TRJ full AI Analyst Report?
TRJ Stock Chart & Stats
AU$0.39
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.39
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.27 - AU$0.97
Previous CloseN/A
Volume3.68K
Average Volume (3M)21.61K
Market Cap
AU$53.50M
Enterprise ValueAU$107.71M
Total Cash (Recent Filing)AU$12.78M
Total Debt (Recent Filing)AU$69.37M
Price to Earnings (P/E)―
Beta0.39
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding152,863,630
10 Day Avg. Volume15,523
30 Day Avg. Volume21,606
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)1.03
Price to Sales (P/S)0.65
P/FCF Ratio16.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.83Price Target Upside111.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.03
Revenue Forecast (FY)AU$171.27M
Bulls Say, Bears Say
Bulls Say
Recurring Consumables BusinessTrajan’s core model of selling consumables and components to labs creates high repeat purchase frequency across life sciences, environmental and food testing markets. This recurring demand provides durable revenue visibility and customer lifetime value, supporting steady cash flows and resilience to single-project volatility.
Steady Revenue GrowthModest mid-single-digit revenue growth demonstrates stable end-market demand and incremental product adoption. Over a 2-6 month horizon this trend supports operational planning and suggests headroom to leverage fixed costs, helping eventual margin recovery if management sustains growth while controlling expenses.
Balanced Leverage / Stable Equity BaseA moderate debt profile and stable equity foundation give Trajan flexibility to fund operations and investments without immediate refinancing stress. This measured leverage supports capital allocation options, helps absorb near-term earnings volatility, and preserves ability to invest in product or distribution initiatives.
Bears Say
Negative Net IncomeSustained net losses and a negative ROE materially weaken internal funding capacity and constrain strategic flexibility. Ongoing unprofitability erodes equity over time, forces prioritization of near-term cost cuts or restructuring, and makes long-term growth plans dependent on restoring consistent operating profits.
Declining Free Cash FlowA 20% drop in free cash flow, despite positive operating cash flow, signals higher capex or working capital absorption that reduces cash available for debt reduction, dividends, or reinvestment. Continued FCF deterioration increases reliance on external financing and limits the firm’s ability to execute strategic investments.
Weak Operating MarginsThe gap between gross margin and low EBIT/EBITDA points to elevated operating expenses or inefficiencies. If SG&A or other operating costs remain structurally high, revenue growth will not translate into sustainable profits, capping scalability and making long-term returns dependent on successful cost rationalization.
Trajan Group Holdings Ltd News
TRJ FAQ
What was Trajan Group Holdings Ltd’s price range in the past 12 months?
Trajan Group Holdings Ltd lowest share price was AU$0.27 and its highest was AU$0.97 in the past 12 months.
What is Trajan Group Holdings Ltd’s market cap?
Trajan Group Holdings Ltd’s market cap is AU$53.50M.
When is Trajan Group Holdings Ltd’s upcoming earnings report date?
Trajan Group Holdings Ltd’s upcoming earnings report date is Sep 02, 2026 which is in 89 days.
How were Trajan Group Holdings Ltd’s earnings last quarter?
Trajan Group Holdings Ltd released its earnings results on Feb 25, 2026. The company reported AU$0.005 earnings per share for the quarter, beating the consensus estimate of -AU$0.004 by AU$0.009.
Is Trajan Group Holdings Ltd overvalued?
According to Wall Street analysts Trajan Group Holdings Ltd’s price is currently Undervalued.
Does Trajan Group Holdings Ltd pay dividends?
Trajan Group Holdings Ltd does not currently pay dividends.
What is Trajan Group Holdings Ltd’s EPS estimate?
Trajan Group Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Trajan Group Holdings Ltd have?
Trajan Group Holdings Ltd has 152,863,630 shares outstanding.
What happened to Trajan Group Holdings Ltd’s price movement after its last earnings report?
Trajan Group Holdings Ltd reported an EPS of AU$0.005 in its last earnings report, beating expectations of -AU$0.004. Following the earnings report the stock price went down -5.042%.
Which hedge fund is a major shareholder of Trajan Group Holdings Ltd?
Currently, no hedge funds are holding shares in AU:TRJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Trajan Group Holdings Ltd Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.83 (111.54% Upside)
AU$0.83 (111.54% Upside)
Insider Transactions
Bought Shares
Worth AU$7.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.50%
12-Months-Change
Fundamentals
Return on Equity
-1.32%
Trailing 12-Months
Asset Growth
-3.37%
Trailing 12-Months
Company Description
Trajan Group Holdings Ltd
Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. The company operates through two segments, Analytical Products and Life Science Solutions. It offers analytical products, including syringes, GC consumables, septas, caps, liners, gas filters, and tubing products; pathology solutions; and sampling products, as well as automation systems for the analysis of biological, food, and environmental samples. The company also provides nutrition testing solutions for pathology laboratories, research and clinical trials, personalized nutrition, corporate wellness, and health insurance. In addition, it offers automation workflow solutions, micro sampling devices, and data analysis services. Trajan Group Holdings Limited was incorporated in 2011 and is headquartered in Ringwood, Australia.
TRJ Stock 12 Month Forecast
Average Price Target
AU$0.83
▲(111.54% Upside)
Technical Analysis
Austco Healthcare Limited
―
Cyclopharm Limited
―
Singular Health Group Ltd
―
EZZ Life Science Holdings Ltd.
―
Arovella Therapeutics Limited
―
Options Prices
Currently, No data available
---